BIOMAT Database Logo BIOMAT Database Logo

Procainamide acetylation and disposition in dialysis patients. 1979

S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Procainamide disposition in obesity.
January 1983, Drug intelligence & clinical pharmacy,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Polymorphic acetylation procainamide in man.
June 1975, Clinical pharmacology and therapeutics,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Acetylation of procainamide in the rat.
October 1979, The Journal of pharmacy and pharmacology,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Procainamide acetylation in strains of rat and mouse.
January 1985, Drug metabolism and disposition: the biological fate of chemicals,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Effect of ranitidine on procainamide disposition.
June 1985, British journal of clinical pharmacology,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Procainamide pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
January 1986, Nephron,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Ethanol-induced increase in procainamide acetylation in man.
February 1982, British journal of clinical pharmacology,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Antinuclear antibodies during procainamide treatment and drug acetylation.
September 1975, British medical journal,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Acetylation of procainamide in man and its relationship to isonicotinic acid hydrazide acetylation phenotype.
April 1975, Clinical pharmacology and therapeutics,
S Nattel, and R I Ogilvie, and J Kreeft, and D S Sitar, and D N Graham, and R E Rangno, and L R Dufresne, and P E Barre
Comparison of the acetylation of procainamide and sulfadimidine in man.
March 1976, European journal of clinical pharmacology,
Copied contents to your clipboard!